Jim Greenwood, BIO
Jim Greenwood set to depart from BIO after US elections — vows to ensure lawmakers don't 'kill innovation'
The herculean US drug lobby is losing one of its flagbearers: BIO CEO Jim Greenwood.
For more than 14 years Greenwood has led BIO, which …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
